Market closed
Inari Medical/$NARI
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Inari Medical
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Ticker
$NARI
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,300
Website
Inari Medical Metrics
BasicAdvanced
$3.2B
Market cap
-
P/E ratio
-$1.35
EPS
1.00
Beta
-
Dividend rate
Price and volume
Market cap
$3.2B
Beta
1
52-week high
$66.61
52-week low
$36.73
Average daily volume
975K
Financial strength
Current ratio
1.77
Quick ratio
1.317
Long term debt to equity
7.164
Total debt to equity
7.527
Interest coverage (TTM)
-106.01%
Management effectiveness
Return on assets (TTM)
-3.21%
Return on equity (TTM)
-17.72%
Valuation
Price to revenue (TTM)
5.6
Price to book
7.45
Price to tangible book (TTM)
41.75
Price to free cash flow (TTM)
2,035.086
Growth
Revenue change (TTM)
22.41%
Earnings per share change (TTM)
2,628.31%
3-year revenue growth (CAGR)
33.33%
3-year earnings per share growth (CAGR)
68.38%
What the Analysts think about Inari Medical
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Inari Medical stock.
Inari Medical Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Inari Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Inari Medical News
AllArticlesVideos
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Inari Medical, Inc. (NARI) and Encourages Stockholders to Learn More About the Investigation
Accesswire·4 days ago
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Investors to Inquire about Securities Investigation
Accesswire·7 days ago
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Inari Medical, Inc. and Encourages Investors to Contact the Firm
Accesswire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Inari Medical stock?
Inari Medical (NARI) has a market cap of $3.2B as of December 22, 2024.
What is the P/E ratio for Inari Medical stock?
The price to earnings (P/E) ratio for Inari Medical (NARI) stock is 0 as of December 22, 2024.
Does Inari Medical stock pay dividends?
No, Inari Medical (NARI) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next Inari Medical dividend payment date?
Inari Medical (NARI) stock does not pay dividends to its shareholders.
What is the beta indicator for Inari Medical?
Inari Medical (NARI) has a beta rating of 1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.